Elite Diosmin
Natural health product licensed in Canada
- Other names
- Elite Riosmin, Elitemed Diosmin, Riosmin Capsules
- Licence holder
- Elitemed Inc.
- NPN or DIN-HM
- 80086126
- Status
- Active licence
- Licence date
- 12 June 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bioflavonoïdes d'agrumes Source : Citrus sinensis - Écorce de fruit Potency : 450 mg Diosmin | Not specified | Not calculated |
| Bioflavonoïdes d'agrumes Source : Citrus sinensis - fruit Potency : 450 mg Diosmin | Not specified | Not calculated |
| Bioflavonoïdes d'agrumes Source : Citrus sinensis - Écorce de fruit Potency : 50 mg Flavonoids expressed as hesperidin | 500 mg | Not calculated |
| Bioflavonoïdes d'agrumes Source : Citrus sinensis - fruit Potency : 50 mg Flavonoids expressed as hesperidin | 500 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Eau purifiée, Cellulose microcristalline, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to relieve symptoms of mild-to-moderate chronic venous insufficiency (CVI), such as pain in the legs, sensation of heaviness, sensation of swelling and functional discomfort.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. If you are taking prescription medication, consult a healthcare practitioner prior to use. If symptoms persist or worsen, consult a health care practitioner. If you suffer, or experience, inflammation of the skin, thrombophlebitis or subcutaneous induration, severe pain, ulcers, sudden swelling of one or both legs, cardiac or renal insufficiency or disorder, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80086126
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.